Once bound, it will inhibit mitochondrial release of cytochrome C (Cyt C) and tumour cell apoptosis.33 We used the co‐immunoprecipitation assay to determine the effect of the combinational treatment on the binding of HK II to VDAC. Here, HK2 is linked to neoplasm.